Alpha-hemoglobin-stabilizing protein (AHSP)

Alpha-hemoglobin-stabilizing protein (AHSP) is an erythroid-specific molecular chaperone that binds free alpha-globin chains in developing erythroid cells. Its principal role is to stabilize alpha-globin and prevent its aggregation and precipitation, which limits oxidative damage and cytotoxicity in erythroid precursors. AHSP promotes proper folding and refolding of alpha-globin, enabling its incorporation into functional hemoglobin (HbA) by facilitating the replacement of AHSP with beta-globin as hemoglobin assembles. AHSP is critical in hemoglobin synthesis, and its deficiency or functional impairment can contribute to the pathology of hemoglobinopathies such as beta-thalassemia and alpha-thalassemia, leading to ineffective erythropoiesis and anemia. AHSP is not a receptor or enzyme, but is classified as a molecular chaperone protein. Its regulation is tied to key erythroid transcription factors (GATA-1, EKLF, and Oct-1), and it is highly conserved across mammalian species. Current clinical interest in AHSP is focused on its biological roles and disease associations, rather than as a direct drug target or biomarker.

Other names

Alpha hemoglobin stabilizing proteinAHSPEDRFERAFErythroid differentiation-related factorErythroid-associated factoralpha hemoglobin stabilising proteinerythroid differentiation associated factorerythroid differentiation-related factor